Metagenomi Therapeutics (MGX) Treasury Shares (2024 - 2026)
Metagenomi Therapeutics (MGX) reported Treasury Shares of $37078.0 for Q1 2026, down 91.36% year-over-year from $429072.0 in Q1 2025, and down 39.34% quarter-over-quarter from $61127.0 in Q4 2025.
Metagenomi Therapeutics (MGX) Treasury Shares (2024 - 2026) Analysis & Trends
Metagenomi Therapeutics (MGX) has 3 years of Treasury Shares data on file, last reported at $37078.0 in Q1 2026.
- Treasury Shares for Q1 2026 came in at $37078.0, down 91.36% year-over-year; the trailing twelve-month figure through Mar 2026 was $37078.0 (down 91.36% YoY), and the FY2025 annual result was $61127.0, down 86.61% from the prior year.
- Treasury Shares declined to $37078.0 in Q1 2026 per MGX's latest filing, from $61127.0 in the prior quarter.
- Over five years, Treasury Shares peaked at $915709.0 in Q1 2024 and troughed at $37078.0 in Q1 2026.
- A 3-year average of $504039.7 and a median of $591646.0 in 2025 frame the typical range for Treasury Shares.
- The sharpest annual moves came in 2025 and 2026: Treasury Shares retreated 0.28% in 2025, then sank 91.36% in 2026.
- A 3-year view of Treasury Shares shows it stood at $456435.0 in 2024, then slumped by 86.61% to $61127.0 in 2025, then tumbled by 39.34% to $37078.0 in 2026.
- Business Quant data shows MGX's Treasury Shares at $37078.0 in Q1 2026, $61127.0 in Q4 2025, and $591646.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 821,726.73 Bn | 821,726.69 Bn | - | - |
| 2 | Belite Bio | 57,768.00 Bn | 57,768.00 Bn | - | - |
| 3 | Quantum Biopharma | 16,655.88 Bn | 16,655.88 Bn | - | - |
| 4 | Legend Biotech | 3,540.00 Bn | 3,539.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,526.26 Bn | 1,526.24 Bn | - | - |
| 6 | Akari Therapeutics | 1,520.09 Bn | 1,520.09 Bn | - | - |
| 7 | Psyence Biomedical | 223.87 Bn | 223.87 Bn | - | 1.48 Mn |
| 8 | Vertex Pharmaceuticals | 114.47 Bn | 107.23 Bn | 2.59 Bn | 700,000.00 |
| 9 | Abivax | 91.22 Bn | 91.22 Bn | - | - |
| 10 | Metagenomi Therapeutics | 42.84 Mn | 42.84 Mn | - | 37,078.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 37,078.00 |
| Mar 31, 2026 | 37,078.00 |
| Dec 31, 2025 | 61,127.00 |
| Dec 31, 2025 | 61,127.00 |
| Sep 30, 2025 | 591,646.00 |
| Sep 30, 2025 | 591,646.00 |
| Jun 30, 2025 | 684,744.00 |
| Jun 30, 2025 | 684,744.00 |
| Mar 31, 2025 | 429,072.00 |
| Mar 31, 2025 | 429,072.00 |
| Dec 31, 2024 | 456,435.00 |
| Dec 31, 2024 | 456,435.00 |
| Sep 30, 2024 | 593,337.00 |
| Sep 30, 2024 | 593,337.00 |
| Jun 30, 2024 | 767,209.00 |
| Jun 30, 2024 | 767,209.00 |
| Mar 31, 2024 | 915,709.00 |
| Mar 31, 2024 | 915,709.00 |